Clinical Trials on Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Pedro Gamito
- IN-JET APS
- UZ Leuven, campus Pellenberg (Belgium)
- JMI Laboratories
- Janssen (China) Research & Development Center
- Stannah Stairlifts
- Hospital Samaritano Paulista
- The Fred Hollows Foundation, Australia
- Hazelden Betty Ford Foundation
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Fogarty International Center of the National Institute of Health
- Familien Hede Nielsens Fond
- Dr. Praveen B.H
- Advanced Life Solutions
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Custom Pharmaceuticals Limited
- Prof. Jacques SCHRENZEL
- Markham Stouffville Hospital
- Physip S.A
- Nestlé Health Science Belgium
- View Full List
Medical Conditions
- Pulmonary Adenocarcinoma
- Tay-Sachs Disease Ganglioside
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Chlamydophila Infections
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Endocarditis Infective
- Predictors of Atrial Fibrillation Recurrences
- Epidemic Hemorrhagic Fever
- Fracture Dislocation of Cervical Spine
- Spine Surgeries
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Ewing's Family Tumors
- Painless Hysteroscopy
- Multisystem Proteinopathy
- Fetus or Neonate Affected by External Version Before Labor
- Gullian Barre Syndrome
- Psoriasis, Arthritic
- Closure; Foramen Ovale
- Skull Base Neoplasms
- Childhood Langerhans Cell Histiocytosis
- View Full List
Drug Interventions
- Redifferentiation with retinoid acid
- EFV +TVA
- Azelastine hydrochloride (BAYR9258)
- High dose pantoprazole infusion
- Adriamycin
- Adapalene Gel 0.3%
- Chemotherapeutic Agent
- Glimepiride
- Cereport
- Estradiol+Drospirenone
- Vehicle
- Qingkailing injection 40 ml
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Esomeprazole 40mg before
- Semapimod
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Palliative care group first-line scheme
- Neihulizumab
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Finland
- Contract Research Organizations in Mali
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Montenegro
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Oman
- Contract Research Organizations in Spain
- Contract Research Organizations in Venezuela
- Contract Research Organizations in Zimbabwe
- CRO list by country